Answers are grounded in this paper and cite their sources.
The surprising ability of thalidomide and its analogs to treat various hematologic malignancies is through the loss of two transcription factors. [Also see Reports by Krönke et al. and Lu et al. ]
No takes yet. Share an insight, caveat, or question.
A. Keith Stewart (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: